Trial Profile
Comparison of Phosphodiesterase-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon, Double Blind, Randomized, Cross-over Trial
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Udenafil (Primary) ; Amlodipine
- Indications Raynaud's disease
- Focus Therapeutic Use
- 01 Apr 2014 New trial record